Showing results (1921-1930 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|November 8, 2011
The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depressionGabriele Masi, Paola BrovedaniCNS Drugs|November 8, 2011
Pharmacogenetics of response to antipsychotics in patients with schizophreniaMaria J Arranz, Margarita Rivera, Janet C MunroCNS Drugs|February 29, 2012
Buprenorphine 5, 10 and 20 μg/h transdermal patch: a guide to its use in chronic non-malignant painGreg L Plosker, Katherine A Lyseng-WilliamsonCNS Drugs|February 16, 2006
SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing?Susanne O Dalton, Henrik T Sørensen, Christoffer JohansenCNS Drugs|November 11, 2016
Neurological and Neuropsychiatric Adverse Effects of Dermatologic MedicationsMelinda Liu, Yuan Yu M Huang, Sylvia Hsu, et al.CNS Drugs|December 23, 2016
Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse PreventionRama M Kamal, Martijn S van Noorden, Wim Wannet, et al.CNS Drugs|March 19, 2014
Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activityMarcelo E Bigal, Sarah WalterCNS Drugs|March 15, 2014
Assessment of the abuse liability of a dual orexin receptor antagonist: a crossover study of almorexant and zolpidem in recreational drug usersHans G Cruz, Petra Hoever, Bijan Chakraborty, et al.CNS Drugs|May 7, 2014
Does pharmacological treatment of ADHD in adults enhance parenting performance? Results of a double-blind randomized trialJames G Waxmonsky, D A Waschbusch, D E Babinski, et al.CNS Drugs|May 9, 2014
Efficacy and safety of intravenous valproate for status epilepticus: a systematic reviewEugen Trinka, Julia Höfler, Alexander Zerbs, et al.Pageof 211